Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chikuma Hamada

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Journal of Cardiology|September 12, 2015
Randomized controlled trial of TY-51924, a novel hydrophilic NHE inhibitor, in acute myocardial infarctionKazuo Kimura, Koichi Nakao, Yoshisato Shibata, et al.
International Journal of Clinical Oncology|January 13, 2017
Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancerTakeshi Suto, Megumi Ishiguro, Chikuma Hamada, et al.
International Journal of Clinical Oncology|June 14, 2017
Erratum to: Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancerTakeshi Suto, Megumi Ishiguro, Chikuma Hamada, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 18, 2015
Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancerHideaki Bando, Yasuhide Yamada, Satoshi Tanabe, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 9, 2016
Impact of progression type on overall survival in patients with advanced gastric cancer based on randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatinKazuhiro Nishikawa, Yasuhide Yamada, Kenji Ishido, et al.
International Journal of Clinical Oncology|January 7, 2016
Meta-analysis supporting noninferiority of oxaliplatin plus S-1 to cisplatin plus S-1 in first-line treatment of advanced gastric cancer (G-SOX study): indirect comparison with S-1 aloneChikuma Hamada, Yasuhide Yamada, Mizutomo Azuma, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Journal of Cardiology|September 12, 2015
Randomized controlled trial of TY-51924, a novel hydrophilic NHE inhibitor, in acute myocardial infarctionKazuo Kimura, Koichi Nakao, Yoshisato Shibata, et al.
International Journal of Clinical Oncology|January 13, 2017
Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancerTakeshi Suto, Megumi Ishiguro, Chikuma Hamada, et al.
International Journal of Clinical Oncology|June 14, 2017
Erratum to: Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancerTakeshi Suto, Megumi Ishiguro, Chikuma Hamada, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 18, 2015
Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancerHideaki Bando, Yasuhide Yamada, Satoshi Tanabe, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 9, 2016
Impact of progression type on overall survival in patients with advanced gastric cancer based on randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatinKazuhiro Nishikawa, Yasuhide Yamada, Kenji Ishido, et al.
International Journal of Clinical Oncology|January 7, 2016
Meta-analysis supporting noninferiority of oxaliplatin plus S-1 to cisplatin plus S-1 in first-line treatment of advanced gastric cancer (G-SOX study): indirect comparison with S-1 aloneChikuma Hamada, Yasuhide Yamada, Mizutomo Azuma, et al.
Pageof 10